ICBP Transition Phase

ICBP Header image

Contact the ICBP team

If you have any views or comments about the  partnership, we would like to hear from you.

Email the team

The ICBP is in a two-year transition phase until March 2023. The partnership will be reflecting on the past 12 years of research and insights to continue to inform international efforts to improve cancer outcomes.

The transition phase will focus on 4 key workstreams: knowledge mobilisation, COVID-19 research, Networks and Phase 3 Scoping.  Phase 3 Scoping will be completed in conjunction with the outputs from the other transition phase modules outlined below, as well as key stakeholder consultation, to inform priority areas.

Deliver effective, relevant, and targeted knowledge mobilisation outputs.

Drawing from 12 years of ICBP data and evidence, the team is liaising with Programme Board members and key stakeholders to produce jurisdiction-specific bespoke materials to support in areas of policy and practice change. The resource page will be updated as materials (infographics, briefings, data reviews, etc.) are made available.

Research internship – Age Disparities

 
Remi is reviewing existing publications for age disparities
Remi Looi-Somoye, PhD candidate, joined the ICBP Programme Management Team as part of a three-month research internship to explore ICBP data demonstrating age disparities in survival and stage distribution. The ICBP SurvMark-2 project, established during the second phase of the ICBP, highlighted that survival for older patients were generally poorer, and that the survival gap between older and younger patients varied across countries. To understand why these differences exist, cancer frameworks, clinical guidelines and cancer pathways were compared between countries. The findings shed light on the differences in geriatric cancer guideline development and implementation, with some countries addressing the growing impact of an ageing population more than others.

 

Commission research to collect intelligence on the impact of COVID-19 on international cancer services and outcomes

The ICBP is in a unique position to build understanding of the international impact of COVID-19 on cancer services and outcomes. The ICBP have commissioned two research projects to work collaboratively to provide evidence-based health policy insights to support mitigation strategies posed by COVID-19 and other future pandemics.

IARC, led by principal investigator Isabelle Soerjamataram, will be assessing the incidence of breast, colon and rectal, ovarian and lung cancer before and during the COVID-19 pandemic, estimating indirect impacts by comparing observed to expected numbers. The team will also be assessing the distribution of cases by stage at diagnosis before and during the COVID-19 pandemic.

The Daffodil Centre, led by principal investigator Karen Canfell, will be using a mixed-methods study design to understand the impact of COVID-19 on cancer services and policies in ICBP jurisdictions through collating policies and practices implemented between 2020 – 2021 in response to COVID-19. The team will also review and evaluate recovery strategies. Click here for the full Daffodil Centre research list.

As this work progresses, look forward to updates here.

Create networks with clinical, academic, and policy insights

The ICBP is in a unique position to bring together clinicians, academics, policy makers and data experts from across its partner jurisdictions to facilitate discussions and explore ICBP priority areas.

The ICBP is creating networks to inform international cancer policy and clinical practice, and to support localised knowledge mobilisation. This section will be updated as activities progress for each of our networks.

Lung Network

This network will host a forum to addresses previous ICBP work showing that partner countries are in very different places regarding support for, and implementation of lung cancer screening. Service providers and key policy colleagues involved in decision-making and development of lung screening implementation strategies will discuss and share lessons learned.

Cancer Intelligence and Data Infrastructure Network

This network has been formed to consider how we can build a resilient and sustainable approach to international benchmarking. The ICBP has demonstrated the value of international collaboration but has also highlighted significant barriers, both in terms of data harmonisation and through cost and logistics. This network will discuss potential methodologies for the future.

Age Inequalities Network

This network will bring together experts and key decision-makers to share knowledge, best practice, and learnings in age inequalities strategy implementation and to better inform potential explanations for why certain jurisdictions may be performing better (or worse) for older patients. Network members will also uniquely collaborate with other networks to provide inequalities insights and knowledge translation support.

Oesophageal and Gastric Cancer Site Deep Dive

The Oesophageal and Gastric network is currently paused, work will commence later this year. Watch this space to find out more, including how you can get involved.

Last reviewed